Bayon Y, Vertès AA, Ronfard V, Culme-Seymour E, Mason C, Stroemer P, et al. Turning regenerative medicine breakthrough ideas and innovations into commercial products. Tissue Eng Part B Rev. 2015;21:560–71.
Blair NF, Frith TJR, Barbaric I. Regenerative medicine: advances from developmental to degenerative diseases. 2017 [cited 2019 Apr 28]. p. 225–239. Available from: http://link.springer.com/10.1007/978-3-319-60733-7_12.
Corbett MS, Webster A, Hawkins R, Woolacott N. Innovative regenerative medicines in the EU: a better future in evidence? BMC Med. 2017;15:49.
Gee AP. Regulation of regenerative medicine products. 2018 [cited 2019 Apr 28]. p. 189–198. Available from: http://link.springer.com/10.1007/978-3-319-97421-7_10
Muraca M, Piccoli M, Franzin C, Tolomeo A, Jurga M, Pozzobon M, et al. Diverging concepts and novel perspectives in regenerative medicine. Int J Mol Sci. 2017;18.
Osakada F. Development of cellular and tissue-based products for retinal regenerative medicine. Yakugaku Zasshi. 2017;137:23–9.
Richards MM, Maxwell JS, Weng L, Angelos MG, Golzarian J. Intra-articular treatment of knee osteoarthritis: from anti-inflammatories to products of regenerative medicine. Phys Sportsmed. 2016;44:101–8.
Terzic A, Pfenning MA, Gores GJ, Harper CM. Regenerative medicine build-out. Stem Cells Transl Med. 2015;4:1373–9.
Dzobo K, Thomford NE, Senthebane DA, Shipanga H, Rowe A, Dandara C, et al. Advances in regenerative medicine and tissue engineering: innovation and transformation of medicine. Stem Cells Int. 2018;2018:1–24.
Hoffman T, Khademhosseini A, Langer RS. Chasing the paradigm: clinical translation of 25 years of tissue engineering. Tissue Eng Part A. 2019.
Hubel A. Impact of freeze–thaw processes on the quality of cells. Cell Gene Ther Insights. 2017;3:807–13.
Hubel A, Carlquist D, Clay M, McCullough J. Liquid storage, shipment, and cryopreservation of cord blood. Transfusion. 2004;44:518–25.
François MM, Copland IB, Yuan S, Romieu-Mourez RR, Waller EK, Galipeau J. Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing. Cytotherapy. 2012;14:147–52.
Hubel A. Preservation of cells: a practical manual. Hoboken, NJ: John Wiley & Sons; 2018.
Freedman L. Reproducibility: life sciences lag in stringent standards. Nature. 2013;504:376.
Betsou F, Lehmann S, Ashton G, Barnes M, Benson EE, Coppola D, et al. Standard preanalytical coding for biospecimens; defining the sample PREanalytical code. Cancer Epidemiol Biomark Prev. 2010;19:1004–11.
Areman E. Cellular therapy: principles, methods, and regulations; 2009. p. 236–50.
Pollock K, Sumstad D, Kadidlo D, McKenna DH, Hubel A. Clinical mesenchymal stromal cell products undergo functional changes in response to freezing. Cytotherapy. 2015;17:38–45.
Pi CH, Yu G, Petersen A, Hubel A. Characterizing the “sweet spot” for the preservation of a T-cell line using osmolytes. Sci Rep. 2018;8:16223.
Solocinski J, Osgood Q, Wang M, Connolly A, Menze, A. M, Chakraborty N. Effect of trehalose as an additive to dimethyl sulfoxide solutions on ice formation, cellular viability, and metabolism. Cryobiology. 2017 [cited 2018 May 9];75:134–143. Available from: https://www.sciencedirect.com/science/article/pii/S0011224016303455
Castro VIB, Craveiro R, Silva JM, Reis RL, Paiva A, Ana AR. Natural deep eutectic systems as alternative nontoxic cryoprotective agents. Cryobiology. 2018;83:15–26.
Yu G, Li R, Hubel A. Interfacial interactions of sucrose during cryopreservation detected by Raman spectroscopy. Langmuir. 2018 [cited 2019 Apr 28];acs.langmuir.8b01616. Available from: http://pubs.acs.org/doi/10.1021/acs.langmuir.8b01616.
Crowe JH, Carpenter JF, Crowe LM. The role of vitrification in anhydrobiosis. Annu Rev Physiol. 1998;60:73–103 Available from: http://www.annualreviews.org/doi/10.1146/annurev.physiol.60.1.73.
Sputtek A, Körber C. Cryopreservation of red blood cells, platelets, lymphocytes, and stem cells. Boca Raton: CRC Press; 1991.
Fahy GM. The relevance of cryoprotectant “toxicity” to cryobiology. Cryobiology. 1986;23:1–13.
Levin RL, Miller TW. An optimum method for the introduction or removal of permeable cryoprotectants: isolated cells. Cryobiology. 1981.
FRASER JK, CAIRO MS, WAGNER EL, McCURDY PR, BAXTER-LOWE LA, CARTER SL, et al. Cord Blood Transplantation Study (COBLT): cord blood bank standard operating procedures. J Hematother. 1998 [cited 2019 Apr 27];7:521–61. Available from: https://www.liebertpub.com/doi/10.1089/scd.1.1998.7.521
Reich-Slotky R, Bachegowda LS, Ancharski M, Mendeleyeva L, Rubinstein P, Rennert H, et al. How we handled the dextran shortage: an alternative washing or dilution solution for cord blood infusions. Transfusion. 2015;55:1147–53.
Hanna J, Hubel A. Preservation of stem cells. Organogenesis. 2009;5:134–7.
Pi C-H, Yu G, Dosa PI, Hubel A. Characterizing modes of action and interaction for multicomponent osmolyte solutions on Jurkat cells. Biotechnol Bioeng 2018 [cited 2019 Jan 4]; Available from: http://doi.wiley.com/10.1002/bit.26880
Pollock K, Yu G, Moller-Trane R, Koran M, Dosa PI, McKenna DH, et al. Combinations of osmolytes, including monosaccharides, disaccharides, and sugar alcohols act in concert during cryopreservation to improve mesenchymal stromal cell survival. Tissue Eng Part C Methods. 2016;22:999–1008.
Mazur P, Leibo SP, Farrant J, Chu EHY, Hanna MG, Smith LH. Interactions of cooling rate, warming rate and protective additive on the survival of frozen mammalian cells. 2008 [cited 2019 Jan 2]. p. 69–88. Available from: http://doi.wiley.com/10.1002/9780470719732.ch5
Mazur P. Principles of cryobiology. Life frozen state: CRC Press; 2004. p. 3–66.
Buckler RL, Kunkel EJ, Thompson ML, Ehrhardt RO. Technological developments for small-scale downstream processing of cell therapies. Cytotherapy. 2016;18:301–6.
Lopez E, Cipri K, Cryobiology VN-C frontiers in, 2012 undefined. Technologies for cryopreservation: overview and innovation. intechopen.com. [cited 2018 Dec 29]; Available from: https://www.intechopen.com/download/pdf/31245
Katayama Y, Yano T, Bessho A, Deguchi S, Sunami K, Mahmut N, et al. The effects of a simplified method for cryopreservation and thawing procedures on peripheral blood stem cells. Bone Marrow Transplant. 1997;19:283–7.
Li R, Yu G, Azarin SM, Hubel A. Freezing responses in DMSO-based cryopreservation of human iPS cells: aggregates versus single cells. Tissue Eng Part C Methods. 2018 [cited 2018 Apr 8];24. Available from: http://www.liebertpub.com/doi/10.1089/ten.tec.2017.0531
Harris CL, Toner M, Hubel A, Cravalho EG, Yarmush ML, Tompkins RG. Cryopreservation of isolated hepatocytes: intracellular ice formation under various chemical and physical conditions. Cryobiology. 1991;28:436–44 Available from: http://www.ncbi.nlm.nih.gov/pubmed/1752131.
Diller KR. Intracellular freezing: effect of extracellular supercooling. Cryobiology. 1975;12:480–5.
Karantalis V, Schulman IH, Balkan W, Hare JM. Allogeneic cell therapy: a new paradigm in therapeutics. Circ Res. 2015;116:12–5.
Pigeau GM, Csaszar E, Dulgar-Tulloch A. Commercial scale manufacturing of allogeneic cell therapy. Front Med. 2018;5 Available from: https://www.frontiersin.org/article/10.3389/fmed.2018.00233/full.
Tedder RS, Zuckerman MA, Brink NS, Goldstone AH, Fielding A, Blair S, et al. Hepatitis B transmission from contaminated cryopreservation tank. Lancet. 1995;346:137–40.
Cosentino LM, Corwin W, Baust JM, Diaz-Mayoral N, Cooley H, Shao W, et al. Preliminary report: evaluation of storage conditions and cryococktails during peripheral blood mononuclear cell cryopreservation. Cell Preserv Technol. 2007;5:189–204 Available from: http://www.liebertpub.com/doi/10.1089/cpt.2007.9987.
Hubel A, Spindler R, Curtsinger JM, Lindgren B, Wiederoder S, McKenna DH. Postthaw characterization of umbilical cord blood: markers of storage lesion. Transfusion. 2015;55:1033–9.
Campbell LD, Astrin JJ, DeSouza Y, Giri J, Patel AA, Rawley-Payne M, et al. The 2018 revision of the ISBER best practices : summary of changes and the editorial team’s development process. Biopreserv Biobank. 2018;16:3–6.
USP. National formulary standards for biologics cryopreservation of cells. Washington, D.C.: US Pharmacop; 2014. p. 1–31.
Karlsson JO. A theoretical model of intracellular devitrification. Cryobiology. 2001;42:154–69 Available from: http://www.ncbi.nlm.nih.gov/pubmed/11578115.
Antonenas V, Bradstock KF, Shaw PJ. Effect of washing procedures on unrelated cord blood units for transplantation in children and adults. Cytotherapy. 2002;4:16.
Zhou X, Liu Z, Shu Z, Ding W, Du P, Chung J, et al. A dilution-filtration system for removing cryoprotective agents. J Biomech Eng. 2011;133:021007 Available from: http://biomechanical.asmedigitalcollection.asme.org/article.aspx?articleid=1421143.
Tostoes R, Dodgson JR, Weil B, Gerontas S, Mason C, Veraitch F. A novel filtration system for point of care washing of cellular therapy products. J Tissue Eng Regen Med. 2017;11:3157–67.
Hanna J, Hubel A, Lemke E. Diffusion-based extraction of DMSO from a cell suspension in a three stream, vertical microchannel. Biotechnol Bioeng. 2012;109:2316–24.
Pegg DE. Viability assays for preserved cells, tissues, and organs. Cryobiology. 1989;26:212–31.
Ragoonanan V, Hubel A, Aksan A. Response of the cell membrane–cytoskeleton complex to osmotic and freeze/thaw stresses. Cryobiology. Academic Press; 2010 [cited 2019 Apr 27];61:335–44. Available from: https://www.sciencedirect.com/science/article/pii/S0011224010003238
Hubel A. Cellular preservation: gene therapy cellular metabolic engineering. Adv Biopreservation. 2006.
Diepart C, Verrax J, Calderon PB, Feron O, Jordan BF, Gallez B. Comparison of methods for measuring oxygen consumption in tumor cells in vitro. Anal Biochem. 2010;396:250–6.
Liu Y, Peterson D, Hideo K, David S. Mechanism of cellular 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction. J Neurochem. 1997;69:581–93 Available from: http://www.ncbi.nlm.nih.gov/pubmed/9231715
Cui D, Li H, Wan M, Peng Y, Xu X, Zhou X, et al. The origin and identification of mesenchymal stem cells in teeth: from odontogenic to non-odontogenic. Curr Stem Cell Res Ther. 2017;13.
Fazeli Z, Abedindo A, Omrani MD, Ghaderian SMH. Mesenchymal stem cells (MSCs) therapy for recovery of fertility: a systematic review. Stem Cell Rev Reports. 2018 [cited 2019 Apr 28];14:1–12. Available from: http://link.springer.com/10.1007/s12015-017-9765-x
Gardner OFW, Alini M, Stoddart MJ. Mesenchymal stem cells derived from human bone marrow. 2015 [cited 2019 Apr 28]. p. 41–52. Available from: http://link.springer.com/10.1007/978-1-4939-2938-2_3
Dzobo K, Turnley T, Wishart A, 2016 Fibroblast-derived extracellular matrix induces chondrogenic differentiation in human adipose-derived mesenchymal stromal/stem cells in vitro. mdpi.com. [cited 2019 Apr 28]; Available from: https://www.mdpi.com/1422-0067/17/8/1259
Lou G, Chen Z, Zheng M, Liu Y. Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases. Exp Mol Med. 2017.
Mao F, Tu Q, Wang L, Chu F, Li X, Li H, et al. Mesenchymal stem cells and their therapeutic applications in inflammatory bowel disease. ncbi.nlm.nih.gov. [cited 2019 Apr 28]; Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514968/
Mohr A, Zwacka R. The future of mesenchymal stem cell-based therapeutic approaches for cancer—from cells to ghosts. Cancer Lett. 2018;414:239–49.
Moreira A, 2017. Therapeutic potential of mesenchymal stem cells for diabetes. jme.bioscientifica.com. [cited 2019 Apr 28]; Available from: https://jme.bioscientifica.com/view/journals/jme/59/3/JME-17-0117.xml
Park WS, Ahn SY, Sung SI, Ahn J-Y, Chang YS. Mesenchymal stem cells: the magic cure for intraventricular hemorrhage? Cell Transplant. 2017;26:439–48.
Dzobo K, Vogelsang M, Parker MI. Wnt/β-catenin and MEK-ERK signaling are required for fibroblast-derived extracellular matrix-mediated endoderm differentiation of embryonic stem cells. Stem Cell Rev Reports. 2015 [cited 2019 Apr 28];11:761–773. Available from: http://link.springer.com/10.1007/s12015-015-9598-4
Fahy GM, Wowk B. Principles of cryopreservation by vitrification. Methods Mol Biol. 2015.